(5-Bromo-2-fluoropyridin-4-yl)methanol, 95%, 500mg

(R)-[2,3':1',1'':3'',2'''-Quaternaphthalene]-2',2''-diol, 97%, 100mg

N*1*-(3-Chloro-5-(trifluoromethyl)pyridin-2-yl)ethane-1,2-diamine, 95.0%, 1g

Zweihalsrundkolben 100 ml NS 29/32

boc-d-asp(ochex)-oh, 95.0%, 5g

(4S,4'S)-4,4'-Dicyclohexyl-1,1'-di-p-tolyl-4,4',5,5'-tetrahydro-1H,1'H-2,2'-biimidazole, 98%, 250mg

(S)-3-Fluoropiperidine hydrochloride, 95+%, 250mg

1-Benzyl-4-iodo-1H-pyrazole>98.0%(GC)1g

N,N'-Diethyl-1,6-diaminohexane>97.0%(GC)(T)25mL

methyl 3-{[3-(dimethylamino)propyl]amino}-2-methylpropanoate, 95.0%, 2g

tert-Butyl 3-(3-methoxy-3-oxopropen-1-yl)indole-1-carboxylate, 250mg

(E)-N-[4-amino-1-(pyridin-4-yl)butylidene]hydroxylamine hydrochloride, 95.0%, 2g

ETHYL 2-AMINO-4-CHLORO-5H-PYRROLO[3,4-D]PYRIMIDINE-6(7H)-CARBOXYLATE, 95.0%, 1g